Clinical trials are the lifeblood of biotech. Finding the right service providers (CROs, safety, IVRS, consultants, contract manufacturers and many others), as well as the right clinical investigators and sites, results in a complex web of legal obligations and potential liabilities. Limitation of liability clauses can reduce a party’s exposure if a contractual obligation is breached. More often, limitations of liability provisions are used to shift risk to the sponsor of the clinical trial. But, if your contracts are well negotiated and drafted, the risks can be carefully and fairly allocated between the parties in a balanced and reasonable manner. Because of the complexity of the legal relationships and liabilities found in clinical trials, this article is limited to a brief description of limitation of liability clauses, and their general strengths and weaknesses.
 

Click here to read full article.

Authored By:

Beni Surpin
(858) 720-8950
bsurpin@sheppardmullin.com

and

Blaine E. Templeman
(212) 332-3854
btempleman@sheppardmullin.com

and

Michael Murphy
(858) 720-7423
mmurphy@sheppardmullin.com